Product Code: ETC340848 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The South Africa pneumonia vaccine market has seen substantial growth due to increasing awareness about the disease and the importance of vaccination. Government initiatives and public health campaigns have played a significant role in boosting vaccine coverage. Additionally, the entry of global vaccine manufacturers and the adoption of advanced vaccination strategies have further strengthened the market.
The pneumonia vaccine market in South Africa is driven by several factors, including increasing awareness about the importance of vaccination in preventing respiratory infections, government initiatives to expand immunization programs, rising incidences of pneumonia among both children and adults, and advancements in vaccine development and delivery methods.
The South Africa pneumonia vaccine market faces significant challenges due to distribution logistics and the high cost of vaccines. Access to remote areas, where the need is often greatest, poses a challenge. Moreover, public awareness campaigns are needed to increase vaccination rates and ensure adequate coverage, particularly among vulnerable populations.
The South African government has implemented a comprehensive vaccination policy aimed at reducing the incidence and severity of pneumonia among its population. This policy includes strategies for the procurement, distribution, and administration of pneumonia vaccines, ensuring that they are accessible and affordable to all citizens, particularly children and vulnerable groups.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Pneumonia Vaccine Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Pneumonia Vaccine Market - Industry Life Cycle |
3.4 South Africa Pneumonia Vaccine Market - Porter's Five Forces |
3.5 South Africa Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 South Africa Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 South Africa Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 South Africa Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Africa Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness about the importance of vaccination in South Africa |
4.2.2 Increasing government initiatives to improve healthcare infrastructure |
4.2.3 Rising incidences of pneumonia cases in the country |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited access to healthcare services in remote areas of South Africa |
5 South Africa Pneumonia Vaccine Market Trends |
6 South Africa Pneumonia Vaccine Market, By Types |
6.1 South Africa Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 South Africa Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 South Africa Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 South Africa Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 South Africa Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 South Africa Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 South Africa Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 South Africa Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 South Africa Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 South Africa Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 South Africa Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 South Africa Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Africa Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 South Africa Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 South Africa Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 South Africa Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 South Africa Pneumonia Vaccine Market Export to Major Countries |
7.2 South Africa Pneumonia Vaccine Market Imports from Major Countries |
8 South Africa Pneumonia Vaccine Market Key Performance Indicators |
8.1 Number of immunization campaigns conducted in South Africa |
8.2 Percentage of children vaccinated against pneumonia in high-risk areas |
8.3 Government investment in healthcare infrastructure improvements |
9 South Africa Pneumonia Vaccine Market - Opportunity Assessment |
9.1 South Africa Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 South Africa Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 South Africa Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 South Africa Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Africa Pneumonia Vaccine Market - Competitive Landscape |
10.1 South Africa Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 South Africa Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |